Published February 14, 2025 | Version v1

A Comprehensive CYP2D6 Drug–Drug–Gene Interaction Network for Application in Precision Dosing and Drug Development

  • 1. ROR icon Saarland University
  • 2. ROR icon Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
  • 3. ROR icon Sanofi (Germany)
  • 4. ROR icon Sanofi (France)
  • 5. Bayer AG, Pharmaceuticals, Research & Development, Model-Informed Drug Development
  • 6. Leiden University Medical Center
  • 7. ROR icon University of Tübingen

Files

CPT_Ruedesheim_2025.pdf

Files (6.3 MB)

Name Size Download all
md5:f9ff8b35064f7cde8907699400ed4406
6.3 MB Preview Download

Additional details

Funding

European Commission
SafePolyMed - Improve Safety in Polymedication by Managing Drug-Drug-Gene Interactions 101057639
Federal Ministry of Education and Research
INSPIRATION - Qualified OpenSystems Pharmacology Modeling Network of Drug–Drug- Gene-Interactions 643272